Renub

    Cardiac Marker Analyzer Market & Product Analysis, By Analyzers (Alere Meterpro Analyzer, RAMP 200, RAMP Reader, etc) & Companies

    Excel: 4 Hours
    PDF: 4 Hours
    Jul 2018
    Pages: 108

    Get Free Customization in This Report

    Global Cardiac Marker Analyzer Market is projected to cross US$ 4 Billion by the year 2024. Cardiac Marker Analyzer (Cardiac Reader Systems) offers high point of care testing results for the diagnosis of cardiac related diseases like myocardial infarction and others. Cardiac Marker Analyzer performs all cardiac monitoring tests such as Troponin, Myoglobin, CK-MB and D-Dimer tests, through immunochromatographic assays. Cardiac marker analyzer efficiency and accuracy can be increased with the help of dedicated software and system which offers extensive support to diagnostic procedures and built in LCD displays for the visualization of practices. 
     
    Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged.  Physicians use cardiac markers in two ways – to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring. 

     

    Request a free sample copy of the report: https://www.renub.com/contactus.php

     

    Some of the major Cardiac Marker Analyzers which are frequently used in the diagnosis of patient’s cardiac conditions include i–STAT System, RAMP Reader, RAMP 200, QL Care Analyzer, Access 2 Immunoassay System, Meritas POC Analyzer, Alere Meterpro Analyzer, PATHFAST Analyzer, Stratus CS Analyzer, Cobas H 232 POC System, ichroma DUO Analyzer and DXpress Reader Analyzer. 

    Cardiac Marker Analyzers plays an important role in the prevention of the misdiagnoses of heart conditions. Increasing prevalence of heart related diseases across the globe and growing awareness among people about the cardiovascular diseases is expected to drive the demand of Cardiac Marker Analyzers for the diagnosis of cardiac diseases. 


    Renub Research report titled “Cardiac Marker Analyzer Market & Product Analysis, By Analyzers (Alere Meterpro Analyzer, RAMP 200, RAMP Reader, The i–STAT System, cobas h 232 POC System, Stratus CS Analyzer, Access 2 Immunoassay System, ichroma DUO Analyzer, DXpress Reader Analyzer, PATHFAST Analyzer, Meritas POC Analyzer, QL Care Analyzer), Companies (Abbott Laboratories, Getein Biotechnology, Siemens Healthcare, Beckman-Coulter, Alere, Response Biomedical, Roche Diagnostics, Boditech, LifeSign, LSI Medience Corporation, Trinity Biotech, CardioGenics)” provides a complete analysis of Cardiac Marker Analyzer Products.

    cardiac-marker-analyzer-product-analysis-business-and-marketing-strategy


    All the 12 Cardiac Marker Analyzers in the report have been studied from 6 viewpoints.

    1.    Cardiac Marker Analyzer Market
    2.    Analyzer Specifications and Benefits 
    3.    Net Product Sales
    4.    Merger, Acquisition & Licensing Agreement
    5.    Marketing Strategies
    6.    Methods of Distribution 

     

    Client can purchase this report in sections through Purchase by Chapter Tab given above


    12 Cardiac Marker Analyzer studied in the report are as follows: 

    1.    Alere Meterpro Analyzer
    2.    RAMP 200
    3.    RAMP Reader
    4.    The i–STAT System
    5.    cobas h 232 POC System
    6.    Stratus CS Analyzer
    7.    Access 2 Immunoassay System
    8.    ichroma DUO Analyzer
    9.    DXpress Reader Analyzer
    10.    PATHFAST Analyzer
    11.    Meritas POC Analyzer
    12.    QL Care Analyzer

     

    Company Analysis

    1.    Abbott Laboratories
    2.   Getein Biotechnology
    3.   Siemens Healthcare
    4.   Beckman-Coulter
    5.   Alere
    6.   Response Biomedical
    7.   Roche Diagnostics
    8.   Boditech
    9.   LifeSign
    10.  LSI Medience Corporation
    11.  Trinity Biotech
    12.  CardioGenics

    1.    Executive Summary

    2.    Cardiac Marker Analyzer Market (2011 – 2024)

    3.    Cardiac Marker Companies – Comparative Tests Analysis

    4.    Cardiac Marker Analyzer – Competitive Product Analysis

    5.    Alere

    5.1    Alere Triage

    5.1.1    Triage MeterPro Analyzer

    5.2    Alere Cardiology Net Sales & Forecast (2011 - 2022)

    6.    Response Biomedical

    6.1    Cardiovascular Testing

    6.1.1    Acute Myocardial Infarction (Heart Attack) Testing
    6.1.2    Congestive Heart Failure (“CHF”) Testing
    6.1.3    Thrombotic Disease Testing

    6.2    RAMP Platform

    6.2.1    RAMP 200
    6.2.2    RAMP Reader

    6.3    Response Biomedical Cardiovascular Net Sales

    7.    Abbott Point of Care

    7.1    The i–STAT System

    7.2    Abbott Laboratories Point of Care Diagnostics Sales (2011 – 2024)

    8.    Roche

    8.1    Cobas h 232 POC System

    9.    Siemens Healthineers

    9.1    Stratus CS Analyzer

    9.2    Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare

    10.    Beckman Coulter

    10.1    Access 2 Immunoassay System

    11.    Boditech

    11.1    i–chroma DUO Analyzer

    12.    Lifesign

    12.1    DXpress Reader Analyzer

    13.    LSI Medience Corporation

    13.1    PATHFAST Analyzer

    14.    Trinity Biotech

    14.1    Meritas POC Analyzer

    14.2    Trinity Biotech Point of Care Diagnostics Sales (2011 – 2024)

    15.    CardioGenics Holdings Inc.

    15.1    QL Care Analyzer

    16.    Mergers, Acquisitions and Licensing Agreements

    16.1    Alere Inc

    16.2    Response Biomedical

    16.3    Abbott Laboratories

    16.4    Siemens Healthineers

    16.5    LSI Medience Corporation

    16.6    Trinity Biotech

    16.7    CardioGenics

    17.    Emerging Markers

    18.    Response Biomedical – Business & Marketing Strategy

    18.1    Reducing Research & Development (R&D) and Sales & Marketing Expenses under the Cost Reduction Strategy

    18.2    New Distributors in China

    18.3    Strategic Alliances with Alere Medical in Japan

    18.4    Response Biomedical Receives Health Canada Approval and CE Mark

    19.    Roche – Business & Marketing Strategy

    19.1    Implementing the Fully Connected Core Laboratory

    19.2    Expansion of Rich Test Menu

    19.3    Broadening the Diagnostics Portfolio

    19.4    Patient Safety Comes First

    20    Siemens Healthineers – Business and Marketing Strategy

    20.1    Siemens Healthineers Announces New Strategic Relationship

    20.2    Cloud-Based Network Teamplay from Siemens Healthineers

    20.3    Strategic Partnership between Siemens and Imricor

    20.4    Siemens Healthineers Offers True High-Sensitivity Troponin I IVD Assay

    20.5    Siemens Healthineers & Digitalization

    20.6    Partnership between Siemens Healthineers and Ebit

    21.    Boditech Med Inc – Business and Marketing Strategy

    21.1    Boditech Med Acquires Immunostics

    21.2    Strong Focus on Manpower and Investments in Research & Development Area

    21.3    Advanced Technology in the Diagnostics Market

    21.4    Marketing Channel

     

    List of Figures:

    Figure 2‑1: Global – Cardiac Marker Market (Billion US$), 2011 - 2017
    Figure 2‑2: Global – Forecast For Cardiac Marker Market (Billion US$), 2018 – 2024

    Figure 5‑1: Worldwide – Alere Cardiology Net Sales (Million US$), 2011 – 2016

    Figure 6‑1: Worldwide – Response Biomedical Cardiovascular Product Sales (Million US$), 2011 – 2016

    Figure 7‑1: Worldwide – Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 – 2017
    Figure 7‑2: Worldwide – Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2018 – 2024

    Figure 8‑1: WIFI Set-up
    Figure 8‑2: QR CODE VIA BARCODE SCANNER Set-up
    Figure 8‑3: QR CODE VIA SMART PHONE APP Set-up
    Figure 8‑4: Connectivity of cobas h 232 in pre-hospital care and within hospital Set-up

    Figure 14‑1: Worldwide – Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2011 – 2017
    Figure 14‑2: Worldwide – Forecast for Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2018 – 2024

    Figure 21‑1: Boditech – R&D Manpower, Jan 2016
    Figure 21‑2: Boditech – R&D Investments (Million US$), Jan 2016

     

    List of Tables:

    Table 2‑1: Cardiac Marker Companies – Comparative Tests Analysis
    Table 2‑2: Cardiac Marker Companies – Comparative Tests Analysis
    Table 2‑3: Cardiac Marker Companies – Comparative Tests Analysis

    Table 3‑1: Cardiac Marker Analyzer – Competitive Product Analysis
    Table 3‑2: Cardiac Marker Analyzer – Competitive Product Analysis

    Table 6‑1: i-STAT 1 Analyzer Specification

    Table 12‑1: PATHFAST – Technical Specifications

    Table 15‑1: Mergers, Acquisitions and Licensing Agreements, 2003 - 2017

    Table 18‑1: Roche - Centralised and Point of Care Solutions Product Launches, 2017
    Table 18‑2: Roche - Molecular Diagnostics Product Launches, 2017
    Table 18‑3: Roche - Tissue Diagnostics Product Launches, 2017
    Table 18‑4: Roche - Sequencing Product Launches, 2017

    • Description
      Price
    • Chapter 1 & 2     Pages : 4
      $500
    • Chapter 3     Pages : 3
      $500
    • Chapter 4     Pages : 2
      $300
    • Chapter 5     Pages : 6
      $100
    • Chapter 6     Pages : 6
      $100
    • Chapter 7     Pages : 5
      $100
    • Chapter 8     Pages : 5
      $100
    • Chapter 9     Pages : 5
      $100
    • Chapter 10     Pages : 3
      $100
    • Chapter 11     Pages : 2
      $100
    • Chapter 12     Pages : 1
      $100
    • Chapter 13     Pages : 4
      $100
    • Chapter 14     Pages : 3
      $100
    • Chapter 15     Pages : 5
      $100
    • Chapter 16     Pages : 10
      $400
    • Chapter 17     Pages : 3
      $400
    • Chapter 18     Pages : 3
      $300
    • Chapter 19     Pages : 8
      $400
    • Chapter 20     Pages : 9
      $400
    • Chapter 21     Pages : 6
      $400

    Related Reports